Concerning the urogenital malignancies, 2/4 (50%) of renal clear cell carcinomas showed intermediate TRPS1 expression (histoscore 8–Figure 2C), whereas the two other cases were negative, as was the case of prostatic adenocarcinoma. The gene discussed is TRPS1; the disease is prostate adenocarcinoma.